Development The Potentiality of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) From Mycelia Extract of Indonesia's Ganoderma Lucidum as Adjuvant Therapy in Patients With Cardiometabolic Syndrome

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
The aim of this study is to determine the role and efficacy of β-1,3/1,6-D-Glucan (Polysaccharide Peptide) from mycelia extract of Indonesia\'s Ganoderma lucidum as an antioxidant and anti-inflammatory agent on cardiometabolic syndrome
Epistemonikos ID: 1699d3f10cb4a3dbb712093f3e2dfde6182d365b
First added on: May 09, 2024